{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:46:17Z","timestamp":1782866777147,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"DOI":"10.1007\/s12028-026-02578-0","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:49:13Z","timestamp":1782863353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Low-Dose Buprenorphine Initiations During Opioid and Sedative Weaning in Mechanically Ventilated Neurocritical Care Patients: A Retrospective Pilot Cohort Study"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9349-0261","authenticated-orcid":false,"given":"David K.","family":"Carroll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandtly","family":"Yakey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark K.","family":"Greenwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Woodcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Isaacson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram A.","family":"Dolcourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Sherma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Muzammil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"issue":"2","key":"2578_CR1","doi-asserted-by":"publisher","first-page":"126","DOI":"10.5005\/jp-journals-10071-23712","volume":"25","author":"H Prabhakar","year":"2021","unstructured":"Prabhakar H, Tripathy S, Gupta N, et al. Consensus statement on analgo-sedation in neurocritical care and review of literature. Indian J Crit Care Med. 2021;25(2):126\u201333. https:\/\/doi.org\/10.5005\/jp-journals-10071-23712. (In eng).","journal-title":"Indian J Crit Care Med"},{"issue":"5","key":"2578_CR2","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s00540-020-02795-7","volume":"34","author":"T Schizodimos","year":"2020","unstructured":"Schizodimos T, Soulountsi V, Iasonidou C, Kapravelos N. An overview of management of intracranial hypertension in the intensive care unit. J Anesth. 2020;34(5):741\u201357. https:\/\/doi.org\/10.1007\/s00540-020-02795-7. (In eng).","journal-title":"J Anesth"},{"issue":"12","key":"2578_CR3","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s40265-020-01338-4","volume":"80","author":"B Sneyers","year":"2020","unstructured":"Sneyers B, Duceppe M-A, Frenette AJ, et al. Strategies for the prevention and treatment of iatrogenic withdrawal from opioids and benzodiazepines in critically ill neonates, children and adults: a systematic review of clinical studies. Drugs. 2020;80(12):1211\u201333. https:\/\/doi.org\/10.1007\/s40265-020-01338-4.","journal-title":"Drugs"},{"key":"2578_CR4","doi-asserted-by":"publisher","unstructured":"Moisa E, Tuculeanu G, Corneci D, Negoita SI, Bilotta F. Iatrogenic withdrawal syndrome in adult intensive care unit: a scoping review. Front Med (Lausanne) 2025;12:1573363. (In eng). https:\/\/doi.org\/10.3389\/fmed.2025.1573363.","DOI":"10.3389\/fmed.2025.1573363"},{"issue":"7","key":"2578_CR5","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1080\/03007995.2021.1928616","volume":"37","author":"S Taesotikul","year":"2021","unstructured":"Taesotikul S, Dilokpattanamongkol P, Tangsujaritvijit V, Suthisisang C. Incidence and clinical manifestation of iatrogenic opioid withdrawal syndrome in mechanically ventilated patients. Curr Med Res Opin. 2021;37(7):1213\u20139. https:\/\/doi.org\/10.1080\/03007995.2021.1928616. (In eng).","journal-title":"Curr Med Res Opin"},{"key":"2578_CR6","doi-asserted-by":"publisher","unstructured":"Fox MA, Carothers C, Dircksen KK, Birrer KL, Choi MJ, Mukkera SR. Prevalence and risk factors for iatrogenic opioid withdrawal in medical critical care patients. Crit Care Explor 2023;5(5):e0904. (In eng). https:\/\/doi.org\/10.1097\/cce.0000000000000904.","DOI":"10.1097\/cce.0000000000000904"},{"issue":"4","key":"2578_CR7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.4037\/aacnacc2019267","volume":"30","author":"CM Arroyo-Novoa","year":"2019","unstructured":"Arroyo-Novoa CM, Figueroa-Ramos MI, Puntillo KA. Opioid and benzodiazepine iatrogenic withdrawal syndrome in patients in the intensive care unit. AACN Adv Crit Care. 2019;30(4):353\u201364. https:\/\/doi.org\/10.4037\/aacnacc2019267. (In eng).","journal-title":"AACN Adv Crit Care"},{"key":"2578_CR8","doi-asserted-by":"publisher","unstructured":"Bouajram RH, Bhatt K, Croci R, et al. Incidence of dexmedetomidine withdrawal in adult critically ill patients: a pilot study. Crit Care Explor 2019;1(8):e0035. (In eng). https:\/\/doi.org\/10.1097\/cce.0000000000000035","DOI":"10.1097\/cce.0000000000000035"},{"issue":"1","key":"2578_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4266\/acc.2022.00094","volume":"37","author":"Y Seo","year":"2022","unstructured":"Seo Y, Lee HJ, Ha EJ, Ha TS. 2021 KSCCM clinical practice guidelines for pain, agitation, delirium, immobility, and sleep disturbance in the intensive care unit. Acute Crit Care. 2022;37(1):1\u201325. https:\/\/doi.org\/10.4266\/acc.2022.00094.","journal-title":"Acute Crit Care"},{"key":"2578_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/jtccm-d-24-00014","author":"Y Sun","year":"2024","unstructured":"Sun Y, Zhao H. Management of intensive care unit withdrawal syndrome. J Transl Critic Care Med. 2024. https:\/\/doi.org\/10.1097\/jtccm-d-24-00014.","journal-title":"J Transl Critic Care Med"},{"issue":"9","key":"2578_CR11","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1345\/aph.1R132","volume":"46","author":"NS Al-Qadheeb","year":"2012","unstructured":"Al-Qadheeb NS, Roberts RJ, Griffin R, Garpestad E, Ruthazer R, Devlin JW. Impact of enteral methadone on the ability to wean off continuously infused opioids in critically ill, mechanically ventilated adults: a case-control study. Ann Pharmacother. 2012;46(9):1160\u20136. https:\/\/doi.org\/10.1345\/aph.1R132.","journal-title":"Ann Pharmacother"},{"issue":"3","key":"2578_CR12","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1177\/0897190019875613","volume":"34","author":"RA Walters","year":"2021","unstructured":"Walters RA, Izquierdo M, Rodriguez JC, Stevens JS, Lavandosky G. Iatrogenic opiate withdrawal in pediatric patients: implementation of a standardized methadone weaning protocol and withdrawal assessment tool. J Pharm Pract. 2021;34(3):417\u201322. https:\/\/doi.org\/10.1177\/0897190019875613.","journal-title":"J Pharm Pract"},{"issue":"2","key":"2578_CR13","doi-asserted-by":"publisher","first-page":"R49","DOI":"10.1186\/cc11250","volume":"16","author":"R Wanzuita","year":"2012","unstructured":"Wanzuita R, Poli-de-Figueiredo LF, Pfuetzenreiter F, Cavalcanti AB, Westphal GA. Replacement of fentanyl infusion by enteral methadone decreases the weaning time from mechanical ventilation: a randomized controlled trial. Crit Care. 2012;16(2):R49. https:\/\/doi.org\/10.1186\/cc11250.","journal-title":"Crit Care"},{"issue":"10","key":"2578_CR14","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1177\/10600280221151106","volume":"57","author":"HA Azimi","year":"2023","unstructured":"Azimi HA, Keats KR, Sulejmani E, Ortiz K, Waller J, Wayne N. Use of methadone versus oxycodone to facilitate weaning of parenteral opioids in critically ill adult patients. Ann Pharmacother. 2023;57(10):1129\u201336. https:\/\/doi.org\/10.1177\/10600280221151106. (In eng).","journal-title":"Ann Pharmacother"},{"issue":"1","key":"2578_CR15","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1177\/0310057X1003800115","volume":"38","author":"Y Shehabi","year":"2010","unstructured":"Shehabi Y, Nakae H, Hammond N, Bass F, Nicholson L, Chen J. The effect of dexmedetomidine on agitation during weaning of mechanical ventilation in critically ill patients. Anaesth Intensive Care. 2010;38(1):82\u201390. https:\/\/doi.org\/10.1177\/0310057X1003800115.","journal-title":"Anaesth Intensive Care"},{"key":"2578_CR16","doi-asserted-by":"publisher","first-page":"129552","DOI":"10.52965\/001c.129552","volume":"13","author":"P Brown","year":"2025","unstructured":"Brown P, Ryder A, Robinson C, Valenti K, Phung K, Hasoon J. Methadone for chronic pain: a review of pharmacology, efficacy, and safety concerns. Health Psychol Res. 2025;13:129552. https:\/\/doi.org\/10.52965\/001c.129552. (In eng).","journal-title":"Health Psychol Res"},{"key":"2578_CR17","doi-asserted-by":"publisher","unstructured":"Chen K, Lu Z, Xin YC, Cai Y, Chen Y, Pan SM. Alpha-2 agonists for long-term sedation during mechanical ventilation in critically ill patients. Cochrane Database Syst Rev 2015;1(1):Cd010269. (In eng). https:\/\/doi.org\/10.1002\/14651858.CD010269.pub2.","DOI":"10.1002\/14651858.CD010269.pub2"},{"key":"2578_CR18","doi-asserted-by":"publisher","DOI":"10.1097\/adm.0000000000001588","author":"DK Carroll","year":"2025","unstructured":"Carroll DK, King A, Yakey B, et al. A novel intravenous buprenorphine micro-infusion strategy: application in critical care and opioid use disorder. J Addict Med. 2025. https:\/\/doi.org\/10.1097\/adm.0000000000001588. (In eng).","journal-title":"J Addict Med"},{"issue":"6","key":"2578_CR19","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1097\/adm.0000000000001214","volume":"17","author":"RF Schult","year":"2023","unstructured":"Schult RF, Maynard KM, Corvelli JM, et al. Low-dose initiation of buprenorphine in hospitalized patients on full agonist opioid therapy: a retrospective observational study. J Addict Med. 2023;17(6):685\u201390. https:\/\/doi.org\/10.1097\/adm.0000000000001214. (In eng).","journal-title":"J Addict Med"},{"issue":"1","key":"2578_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/cns.13134","volume":"26","author":"Q Gao","year":"2020","unstructured":"Gao Q, Yuan F, Yang XA, et al. Development and validation of a new score for predicting functional outcome of neurocritically ill patients: The INCNS score. CNS Neurosci Ther. 2020;26(1):21\u20139. https:\/\/doi.org\/10.1111\/cns.13134. (In eng).","journal-title":"CNS Neurosci Ther"},{"key":"2578_CR21","doi-asserted-by":"publisher","unstructured":"The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update. J Addict Med 2020;14(2S Suppl 1):1\u201391. (In eng). https:\/\/doi.org\/10.1097\/adm.0000000000000633.","DOI":"10.1097\/adm.0000000000000633"},{"issue":"4","key":"2578_CR22","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/ajad.13135","volume":"30","author":"S Ahmed","year":"2021","unstructured":"Ahmed S, Bhivandkar S, Lonergan BB, Suzuki J. Microinduction of buprenorphine\/naloxone: a review of the literature. Am J Addict. 2021;30(4):305\u201315. https:\/\/doi.org\/10.1111\/ajad.13135. (In eng).","journal-title":"Am J Addict"},{"key":"2578_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2147\/sar.S109919","volume":"7","author":"R H\u00e4mmig","year":"2016","unstructured":"H\u00e4mmig R, Kemter A, Strasser J, et al. Use of microdoses for induction of buprenorphine treatment with overlapping full opioid agonist use: the “Bernese method” Subst Abuse Rehabil. 2016;7:99\u2013105. https:\/\/doi.org\/10.2147\/sar.S109919. (In eng).","journal-title":"Subst Abuse Rehabil"},{"issue":"3","key":"2578_CR24","doi-asserted-by":"publisher","DOI":"10.1097\/cce.0000000000001062","volume":"6","author":"DJ Vanini","year":"2024","unstructured":"Vanini DJ, Corvelli JM, Maynard KM, et al. Practices and outcomes associated with sublingual buprenorphine use in a critically ill population. Crit Care Explor. 2024;6(3):e1062. https:\/\/doi.org\/10.1097\/cce.0000000000001062. (In eng).","journal-title":"Crit Care Explor"},{"issue":"5","key":"2578_CR25","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/clpt.1994.71","volume":"55","author":"SL Walsh","year":"1994","unstructured":"Walsh SL, Preston KL, Stitzer ML, Cone EJ, Bigelow GE. Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clin Pharmacol Ther. 1994;55(5):569\u201380. https:\/\/doi.org\/10.1038\/clpt.1994.71. (In eng).","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"2578_CR26","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1097\/adm.0000000000001488","volume":"19","author":"J Moore","year":"2025","unstructured":"Moore J, Gangemi A. Low-dose buprenorphine initiation in an intubated and sedated patient: a case report. J Addict Med. 2025;19(6):737\u20139. https:\/\/doi.org\/10.1097\/adm.0000000000001488. (In eng).","journal-title":"J Addict Med"},{"issue":"1","key":"2578_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-024-01028-4","volume":"21","author":"L Szczesniak","year":"2024","unstructured":"Szczesniak L, Britton S, Rn TB, Sullivan R. Low-dose overlap initiation with split tablets of buprenorphine in intubated intensive care unit patients with opioid use disorder. Harm Reduct J. 2024;21(1):114. https:\/\/doi.org\/10.1186\/s12954-024-01028-4. (In eng).","journal-title":"Harm Reduct J"},{"issue":"4","key":"2578_CR28","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.mcna.2020.03.003","volume":"104","author":"M Herscher","year":"2020","unstructured":"Herscher M, Fine M, Navalurkar R, Hirt L, Wang L. Diagnosis and management of opioid use disorder in hospitalized patients. Med Clin North Am. 2020;104(4):695\u2013708. https:\/\/doi.org\/10.1016\/j.mcna.2020.03.003. (In eng).","journal-title":"Med Clin North Am"},{"issue":"22","key":"2578_CR29","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1001\/jama.289.22.2983","volume":"289","author":"EW Ely","year":"2003","unstructured":"Ely EW, Truman B, Shintani A, et al. Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA. 2003;289(22):2983\u201391. https:\/\/doi.org\/10.1001\/jama.289.22.2983. (In eng).","journal-title":"JAMA"},{"key":"2578_CR30","doi-asserted-by":"publisher","unstructured":"Sessler CN, Gosnell MS, Grap MJ, et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med 2002;166(10):1338\u201344. (In eng). https:\/\/doi.org\/10.1164\/rccm.2107138.","DOI":"10.1164\/rccm.2107138"},{"issue":"3","key":"2578_CR31","doi-asserted-by":"publisher","first-page":"e711","DOI":"10.1097\/ccm.0000000000006574","volume":"53","author":"K Lewis","year":"2025","unstructured":"Lewis K, Balas MC, Stollings JL, et al. A focused update to the clinical practice guidelines for the prevention and management of pain, anxiety, agitation\/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med. 2025;53(3):e711\u201327. https:\/\/doi.org\/10.1097\/ccm.0000000000006574. (In eng).","journal-title":"Crit Care Med"},{"key":"2578_CR32","doi-asserted-by":"publisher","unstructured":"Pearson SD, Patel BK. Evolving targets for sedation during mechanical ventilation. Curr Opin Crit Care 2020;26(1):47\u201352. (In eng). https:\/\/doi.org\/10.1097\/mcc.0000000000000687.","DOI":"10.1097\/mcc.0000000000000687"},{"key":"2578_CR33","doi-asserted-by":"publisher","unstructured":"McPherson ML. Why equianalgesic tables are only part of the answer to equianalgesia. Ann Palliat Med 2020;9(2):537\u2013541. (In eng). https:\/\/doi.org\/10.21037\/apm.2020.03.05.","DOI":"10.21037\/apm.2020.03.05"},{"key":"2578_CR34","doi-asserted-by":"publisher","unstructured":"Erstad BL, Glenn MJ. Management of critically ill patients receiving medications for opioid use disorder. Chest 2024;165(2):356\u2013367. (In eng). https:\/\/doi.org\/10.1016\/j.chest.2023.10.024.","DOI":"10.1016\/j.chest.2023.10.024"},{"key":"2578_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.hmedic.2024.100070","volume":"5","author":"M Alfayoumi","year":"2024","unstructured":"Alfayoumi M, Ananthegowda DC, Mohamed AE, Nashwan AJ. edative-hypnotic withdrawal syndrome treated with phenobarbital: a case report. Medical Reports. 2024;5:100070. https:\/\/doi.org\/10.1016\/j.hmedic.2024.100070.","journal-title":"Medical Reports"},{"issue":"4","key":"2578_CR36","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s13181-014-0430-3","volume":"10","author":"TE Albertson","year":"2014","unstructured":"Albertson TE, Chenoweth J, Ford J, Owen K, Sutter ME. Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes? J Med Toxicol. 2014;10(4):369\u201381. https:\/\/doi.org\/10.1007\/s13181-014-0430-3. (In eng).","journal-title":"J Med Toxicol"},{"key":"2578_CR37","doi-asserted-by":"publisher","unstructured":"Roberts KJ, Goodfellow LT, Battey-Muse CM, et al. AARC Clinical Practice Guideline: spontaneous breathing trials for liberation from adult mechanical ventilation. Respir Care 2024;69(7):891\u2013901. In eng. https:\/\/doi.org\/10.4187\/respcare.11735.","DOI":"10.4187\/respcare.11735"},{"issue":"2","key":"2578_CR38","first-page":"65","volume":"4","author":"H Zein","year":"2016","unstructured":"Zein H, Baratloo A, Negida A, Safari S. Ventilator weaning and spontaneous breathing trials; an educational review. Emerg (Tehran). 2016;4(2):65\u201371 (In eng).","journal-title":"Emerg (Tehran)"},{"key":"2578_CR39","doi-asserted-by":"publisher","unstructured":"Dunn KE, Bird HE, Bergeria CL, Ware OD, Strain EC, Huhn AS. Operational definition of precipitated opioid withdrawal. Front Psychiatry 2023;14:1141980. (In eng). https:\/\/doi.org\/10.3389\/fpsyt.2023.1141980.","DOI":"10.3389\/fpsyt.2023.1141980"},{"key":"2578_CR40","doi-asserted-by":"publisher","unstructured":"Witcraft EJ, Gonzales JP, Seung H, et al. Continuation of opioid therapy at transitions of care in critically ill patients. J Intensive Care Med 2021;36(8):879\u2013884. (In eng). https:\/\/doi.org\/10.1177\/0885066620933798.","DOI":"10.1177\/0885066620933798"},{"issue":"11","key":"2578_CR41","first-page":"1346","volume":"37","author":"N Matsumiya","year":"1988","unstructured":"Matsumiya N, Shimizu H, Fujita S, Mayumi T. Effect of butorphanol and buprenorphine on cerebrospinal fluid pressure. Masui. 1988;37(11):1346\u201350 (In jpn).","journal-title":"Masui"},{"key":"2578_CR42","doi-asserted-by":"crossref","unstructured":"Souza APd, Rezende MLd, Nunes N, Nishimori CT, Santos PSPd, Paula DPd. Altera\u00e7\u00f5es cardiovasculares e intracranianas promovidas pela buprenorfina em c\u00e3es anestesiados com desflurano. Ci\u00eancia Rural 2004;34(3):815\u2013820. (In Portuguese).","DOI":"10.1590\/S0103-84782004000300025"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-026-02578-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12028-026-02578-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-026-02578-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:49:23Z","timestamp":1782863363000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12028-026-02578-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":42,"alternative-id":["2578"],"URL":"https:\/\/doi.org\/10.1007\/s12028-026-02578-0","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"1 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Greenwald is a paid consultant for, and unpaid coauthor with, Indivior Inc. regarding buprenorphine treatment; Indivior played no role in this project. All other authors (D.K.C., A.M.K., B.Y., E.A.W., A.R.I., B.A.D., A.S., and M.M.) have no conflicts of interest to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"The study was approved by the Detroit Medical Center Institutional Review Board (protocol no. 21594) and the Wayne State University Institutional Review Board (IRB-24\u201302-6606). A waiver of informed consent was granted because the study involved retrospective review of existing records with abstraction of de-identified data and was determined to represent minimal risk to participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approvals and Informed Consent"}},{"value":"No AI tools were used in the preparation, writing, or editing of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Artificial Intelligence (AI) Statement"}}]}}